Interferon therapy
PSYCHIATRIC DISORDERS INDUCED BY INTERFERON THERAPY OF CHRONIC HEPATITIS C PATIENTS: LONGITUDINAL STUDY
... pegylated interferon alpha (IFN Peg) and ...pegylated interferon alpha and Ribavirin (PEG-IFN- α + RBV) in a Moroccan patient ...combination therapy with pegylated interferon alpha with ...
8
Comparison of HCV Plus-and Minus-Strand RNA in PBMCs of Responders and non-Responders of Chronically Infected Patients Receiving Ribavirin and Interferon Therapy
... 5. Polyak SJ, McArdle S, Liu SL, Sullivan DG, Chung M, Hofgartner WT, et al. Evolution of hepatitis C virus quasispecies in hypervariable region 1 and the putative interferon sensitivity- determining region during ...
8
Analysis of Mutations within the 5′ Untranslated Region, Interferon Sensitivity Region, and PePHD Region as a Function of Response to Interferon Therapy in Hepatitis C Virus Infected Patients in India
... the interferon-inducible cellular PKR ...to interferon therapy; however, the results of different studies are conflicting and not sufficiently ...to interferon therapy between the ...
7
Analysis of the factors motivating HCV infected patients to accept interferon therapy
... combination therapy were studied (Table ...feron therapy and 22 had relapsed after previous IFN ...IFN therapy and participants in a clinical ...
7
Identifying responders and nonresponders to interferon therapy in multiple sclerosis
... of therapy: the condition of the patient before treatment and adaptive changes during therapy, eg, certain human leukocyte antigen alleles, or single nucleotide polymorphisms in the interferon ...
10
Genetic Heterogeneity of Hypervariable Region 1 of the Hepatitis C Virus (HCV) Genome and Sensitivity of HCV to Alpha Interferon Therapy
... IFN-␣ therapy was associated with an increased rate of fixation of mutations in the HVR-1 region compared to the same region in untreated patients, supporting the idea that IFN-␣ acts partially via ...
8
Bone mineral density and cytokine levels during interferon therapy in children with chronic hepatitis B: does interferon therapy prevent from osteoporosis?
... Interleukins and lymphokines may play a role in the bone remodeling process [1]. The calcitonin-like effect of IFN- γ is difficult to interpret if one assumes that the immune interferon actually brings about the ...
8
Regulation of interferon receptor expression in human blood lymphocytes in vitro and during interferon therapy
... Cellular binding assays were performed on these cells in order to generate specific binding curves for the quantitative determination of receptor sites.. In this experiment, the control [r] ...
8
Pilot Interferon- Trial in Children With Chronic Hepatitis B Who Had Previously Not Responded to Interferon- Therapy
... The inclusion criteria of this pilot study were children with CHB who were nonresponders to previous IFN- a treatment and had HBV replicative markers (serum HBV DNA and hepatitis B e ant[r] ...
6
Effect of adjuvant interferon therapy on hepatitis B virus related hepatocellular carcinoma: a systematic review
... and mortality of liver cancer had significant differences between interferon group and the control group. But, there is no statistical significance on the recurrence rate and mortality of HBV-related ...
8
Retreatment of hepatitis C non-responsive to Interferon. A placebo controlled randomized trial of Ribavirin monotherapy versus combination therapy with Ribavirin and Interferon in 121 patients in the Benelux [ISRCTN53821378]
... JB: Interferon and ribavirin for patients with chronic hepatitis C who did not respond to previous interferon therapy: a meta-analysis of controlled and uncontrolled ...with interferon plus ...
9
AMINO ACID SEQUENCE VARIATIONS WITHIN ENVELOPED PROTEIN 2 (E2) OF HEPATITIS C VIRUS SUBTYPE 3a AND RESPONSE TO INTERFERON ALPHA PLUS RIBAVIRIN COMBINATION THERAPY
... with Interferon therapy most of the previous studies were focused on the Interferon sensitive determining region (ISDR) from non structure protein 5A (NS5A) and RNA-dependent protein kinase ...
12
Clinical analysis of kasabach-merritt syndrome in 17 neonates
... vincristine therapy was useful in patients who were resistant to steroid and interferon therapy ...steroid therapy and arterial embolization, and was effective in 80% of these ...vincristine ...
7
GAMMA GLUTAMYL TRANSFERASE IN PREDICTION OF EVR IN PATIENTS WITH CHRONIC HEPATITIS C TREATED WITH PEGYLATED INTERFERON AND RIBAVIRIN COMBINATION THERAPY
... to interferon therapy such as decompensated liver disease, psychological disorders, thyroid dysfunction, autoimmune diseases, uncontrolled diabetes or patients who developed significant side effects in ...
10
Fast relapse and high drop out rate of 48 weeks daily interferon monotherapy in HIV infected patients with chronic hepatitis C
... of interferon. Malaise, fatigue and fever, so strong to stop the therapy, were recorded in 8 patients ...to interferon therapy was difficult even in pa- tients who did not experience side ...
6
Cytokine Responses in Severe Acute Respiratory Syndrome Coronavirus-Infected Macrophages In Vitro: Possible Relevance to Pathogenesis
... beta interferon (IFN-  ), forward (3 ⬘ -GCC GCA TTG ACC ATC T-5 ⬘ ) and reverse (3⬘-CAC AGT GAC TGT ACT CCT-5⬘); for CXCL10/IFN-␥-inducible protein 10 (IP-10), forward (3 ⬘ -CTG ACT CTA AGT GGC ATT-5 ⬘ ) and ...
8
Therapeutic algorithms for chronic hepatitis C in the DAA era during the current economic crisis: whom to treat? How to treat? When to treat?
... stopping therapy in both naive and experi- enced G1 CHC patients treated with TVR if HCV RNA >1000 at week 4 (stop only TVR) or at week 12 (stop all drugs) ...stop therapy in case of detectable HCV RNA ...
7
Use of Whole Blood Specimens for Routine Clinical Quantitation of Hepatitis C Virus RNA Does Not Increase Assay Sensitivity
... The measurement of hepatitis C virus (HCV) RNA levels in the blood has, in the last few years, become a critical component in the therapy of patients with HCV infections. Initially, extraction methods for serum ...
6
Modulating host immune responses to fight invasive fungal infections
... Immune modulation in HIV-associated mycoses remains complicated by the risk of immune reconstitution inflammatory syndrome and although exogenous interferon-gamma therapy may be benef[r] ...
28
Original Article Efficacy analysis of the aminolevulinic acid photodynamic therapy combined with recombinant human interferon α-2b ointment in the treatment of precancerous skin lesions and superficial basal cell carcinoma in elderly patients
... tion. Interferon is a common adjuvant drug for clinical anti-tumor therapy, which inhibits the synthesis of tumor cell genes, and induces necrosis and apoptosis of tumor ...
7